BRPI0607773A2 - método para produção de um oligÈmero de proantocianidina - Google Patents

método para produção de um oligÈmero de proantocianidina

Info

Publication number
BRPI0607773A2
BRPI0607773A2 BRPI0607773-0A BRPI0607773A BRPI0607773A2 BR PI0607773 A2 BRPI0607773 A2 BR PI0607773A2 BR PI0607773 A BRPI0607773 A BR PI0607773A BR PI0607773 A2 BRPI0607773 A2 BR PI0607773A2
Authority
BR
Brazil
Prior art keywords
ring structure
oligomer
substance
composition
resorcinol
Prior art date
Application number
BRPI0607773-0A
Other languages
English (en)
Inventor
Takashi Tanaka
Gen-Ichiro Nonaka
Isao Kohno
Hajime Fujii
Takashi Nakagawa
Hiroshi Nishioka
Original Assignee
Univ Nagasaki
Usaien Pharmaceutical Co Ltd
Amino Up Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nagasaki, Usaien Pharmaceutical Co Ltd, Amino Up Chemical Co Ltd filed Critical Univ Nagasaki
Publication of BRPI0607773A2 publication Critical patent/BRPI0607773A2/pt
Publication of BRPI0607773B1 publication Critical patent/BRPI0607773B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/04—Rhodophycota or rhodophyta (red algae), e.g. Porphyra
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/14—Cupressaceae (Cypress family), e.g. juniper or cypress
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/485—Gueldenstaedtia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2
    • C07D311/62—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2 with oxygen atoms directly attached in position 3, e.g. anthocyanidins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Birds (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)

Abstract

MéTODO PARA PRODUçãO DE UM OLIGÈMERO DE PROANTOCIANIDINA. A presente invenção refere-se a uma composição contendo como seu principal componente um oligómero de proantocianidina, ao qual se liga uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol, a qual reduz o peso molecular e que é obtida através do aquecimento de materiais de plantas contendo o polímero de proantocianidina ou extrato do mesmo, com uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol em uma solução aquosa acídica, a um método de produção da dita composição, e ao uso da dita composição em produtos para preservação da saúde e produtos farmacêuticos. De acordo com a invenção, o oligómero de proantocianidina tendo atividade fisiológica, ao qual uma substância apresentando uma estrutura de anel de floroglicinol ou estrutura de anel de resorcinol, se liga e tem peso molecular reduzido em um tal nível que o oligómero possa ser absorvido no corpo humano, o que foi convencionalmente difícil de se obter com alta produção de matérias-primas de plantas, pode ser eficiente e facilmente produzido.
BRPI0607773-0A 2005-02-25 2006-02-24 Método para produção de um oligômero de proantocianidina BRPI0607773B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2005051070 2005-02-25
JP2005-051070 2005-02-25
PCT/JP2006/303402 WO2006090830A1 (ja) 2005-02-25 2006-02-24 プロアントシアニジンオリゴマーの製造方法

Publications (2)

Publication Number Publication Date
BRPI0607773A2 true BRPI0607773A2 (pt) 2009-10-06
BRPI0607773B1 BRPI0607773B1 (pt) 2019-07-23

Family

ID=36927463

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0607773-0A BRPI0607773B1 (pt) 2005-02-25 2006-02-24 Método para produção de um oligômero de proantocianidina

Country Status (14)

Country Link
US (2) US20090047305A1 (pt)
EP (1) EP1852430B1 (pt)
JP (1) JP4941991B2 (pt)
KR (2) KR101366187B1 (pt)
CN (1) CN101133043B (pt)
AU (1) AU2006216182A1 (pt)
BR (1) BRPI0607773B1 (pt)
CA (1) CA2599295C (pt)
DK (1) DK1852430T3 (pt)
ES (1) ES2746955T3 (pt)
NZ (1) NZ560436A (pt)
PL (1) PL1852430T3 (pt)
RU (1) RU2435579C2 (pt)
WO (1) WO2006090830A1 (pt)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090047305A1 (en) 2005-02-25 2009-02-19 Nagasaki University Method of producing proanthocyanidin oligomer
JP2008156265A (ja) * 2006-12-22 2008-07-10 Yamagata Prefecture Ａ型プロアントシアニジンオリゴマー画分及びその製造方法
JP5160149B2 (ja) * 2007-06-22 2013-03-13 明治薬品株式会社 柿ポリフェノールオリゴマー
FR2923718B1 (fr) * 2007-11-15 2009-12-18 Caudalie Compositions de derives polyphenoliques flavonoidiques et leurs applications pour lutter contre les pathologies et le vieillissement des organismes vivants
US20110027399A1 (en) * 2008-03-31 2011-02-03 Hiroshima University Antiviral Agent and Antiviral Composition
CA2725546C (en) * 2008-05-09 2018-07-31 Mount Sinai School Of Medicine Of New York University Grape seed extract and use thereof for treating a neurodegenerative disease
JP5856728B2 (ja) 2009-07-21 2016-02-10 国立大学法人金沢大学 ポリフェノールを配合してなる経口投与用又は外用組成物、並びにその用途
CN102224923B (zh) * 2011-04-26 2012-08-08 乌鲁木齐富润东方生物科技有限公司 一种改性苹果多酚的制备方法
WO2012163588A2 (en) 2011-05-27 2012-12-06 Unilever Plc Anti-ageing composition
CN103561767A (zh) * 2011-05-27 2014-02-05 荷兰联合利华有限公司 用于预防或治疗动脉粥样硬化的聚苯酚组合物
CN103561768B (zh) * 2011-05-27 2016-11-16 荷兰联合利华有限公司 抗炎组合物
CN102433125A (zh) * 2011-08-31 2012-05-02 新疆富润贸易有限公司 一种改性葡萄籽多酚及其制备方法
JP2013087102A (ja) * 2011-10-20 2013-05-13 Hiroshima Univ バナナ等抽出物を有効成分とする非エンベロープウイルスに対する抗ウイルス剤
JP6047812B2 (ja) * 2011-10-20 2016-12-21 国立大学法人広島大学 カリン等抽出物を有効成分とするノロウイルス属に属する非エンベロープウイルスに対する抗ウイルス剤
CN102617535B (zh) * 2012-02-24 2014-08-20 浙江大学 从杨梅叶中提取原飞燕草素的方法
CN102924422B (zh) * 2012-09-10 2015-03-11 华南理工大学 脉冲电场强化降解制备低聚原花青素的方法
WO2014054174A1 (ja) * 2012-10-05 2014-04-10 フジッコ株式会社 低重合度プロアントシアニジンの製法およびそれにより得られる低重合度プロアントシアニジン
CN103183967A (zh) * 2013-04-28 2013-07-03 湖南农业大学 一种以新鲜樟树果皮生产紫色素的方法
TW201733605A (zh) * 2016-02-29 2017-10-01 明治股份有限公司 可可水萃物、含它之飲食品、可可萃取物之製造方法、及多酚之萃取方法
JP7609558B2 (ja) * 2017-08-28 2025-01-07 株式会社Ｎｂｃメッシュテック ポリフェノールの製造方法
CN108299370B (zh) * 2018-04-09 2021-12-07 上海永姿化妆品有限公司 一种用于护肤乳液的生物抗氧化剂的合成方法
JP7210190B2 (ja) * 2018-08-28 2023-01-23 セッツ株式会社 抗ノロウイルス剤、消毒剤及び洗浄剤
CN111034902B (zh) * 2019-12-13 2023-03-28 汕头大学 一种高稳定性的色素衍生物及其制备方法
WO2022205137A1 (zh) * 2021-03-31 2022-10-06 贝尔克斯生技股份有限公司 高聚原花青素组合物及其应用
WO2022241749A1 (zh) * 2021-05-21 2022-11-24 浙江大学 一种原飞燕草素b9没食子酸酯的化学合成方法
CN113429371B (zh) * 2021-05-21 2022-06-21 浙江大学 一种原飞燕草素b9没食子酸酯的化学合成方法
JP7679064B2 (ja) * 2021-06-15 2025-05-19 国立大学法人信州大学 ガレート型エピカテキン重合体又はガレート型エピガロカテキン重合体の製造方法
KR102766105B1 (ko) 2022-01-24 2025-02-13 경희대학교 산학협력단 저분자 페놀 화합물을 포함하는 수소화 분해된 적송수피 추출물을 유효성분으로 함유하는 알츠하이머병 예방 또는 치료용 조성물 및 이의 제조방법
CN116120336B (zh) * 2023-02-17 2024-11-19 江南大学 一种木瓜原花青素及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120818A (ja) * 1983-12-01 1985-06-28 Sanko Seibutsu Kagaku Kenkyusho:Kk 健康茶
JPH0762014B2 (ja) 1992-07-29 1995-07-05 株式会社北條製▲餡▼所 プロアントシアニジンの製造方法
CA2250792C (en) 1996-04-02 2011-09-13 Mars, Incorporated Cocoa extract compounds and methods for making and using the same
DE60030276T2 (de) 1999-04-23 2007-08-30 Kyowa Hakko Kogyo Co., Ltd. Verfahren zur reinigung von proanthocyanidin-oligomeren
KR100690980B1 (ko) * 1999-07-16 2007-03-12 주식회사 벤스랩 콜레스테롤 분해용 음료 및 분해용 제재
KR100509119B1 (ko) * 1999-07-16 2005-08-18 주식회사 엘지생활건강 프로시아니딘 올리고머를 유효성분으로 하는 약제
FR2802812B1 (fr) * 1999-12-22 2002-08-23 Serobiologiques Lab Sa Utilisation de residus issus de la fabrication du vin pour la fabrication de preparations cosmetiques et/ou pharmaceutiques.
JP3595816B2 (ja) 2002-04-24 2004-12-02 株式会社東洋新薬 プロアントシアニジン含有物の製造方法
JP3568201B1 (ja) * 2002-07-29 2004-09-22 株式会社東洋新薬 健康食品および健康飲料
CA2488394C (en) * 2003-05-26 2013-09-24 Amino Up Chemical Co., Ltd. Sulfur-containing proanthocyanidin oligomer composition and production method thereof
US20090047305A1 (en) 2005-02-25 2009-02-19 Nagasaki University Method of producing proanthocyanidin oligomer

Also Published As

Publication number Publication date
CN101133043A (zh) 2008-02-27
JPWO2006090830A1 (ja) 2008-07-24
DK1852430T3 (da) 2019-08-05
AU2006216182A1 (en) 2006-08-31
ES2746955T3 (es) 2020-03-09
KR101366187B1 (ko) 2014-02-21
US20160151329A1 (en) 2016-06-02
WO2006090830A1 (ja) 2006-08-31
RU2435579C2 (ru) 2011-12-10
JP4941991B2 (ja) 2012-05-30
KR20070110040A (ko) 2007-11-15
CA2599295C (en) 2014-10-14
EP1852430B1 (en) 2019-07-03
NZ560436A (en) 2011-03-31
CA2599295A1 (en) 2006-08-31
KR20130128017A (ko) 2013-11-25
CN101133043B (zh) 2012-10-10
RU2007135274A (ru) 2009-03-27
US10183007B2 (en) 2019-01-22
US20090047305A1 (en) 2009-02-19
BRPI0607773B1 (pt) 2019-07-23
EP1852430A4 (en) 2011-10-12
PL1852430T3 (pl) 2020-03-31
EP1852430A1 (en) 2007-11-07

Similar Documents

Publication Publication Date Title
BRPI0607773A2 (pt) método para produção de um oligÈmero de proantocianidina
Caro-Ordieres et al. The coming age of flavonoids in the treatment of diabetic complications
Oh Bioactive compounds and their neuroprotective effects in diabetic complications
BRPI0910832B8 (pt) derivados de tienopiridona como ativadores de proteína quinase ativada por amp (ampk), seus usos, seu processo de preparação e seus intermediários, e medicamentos.
BRPI0910439B8 (pt) derivados de tienopiridona como ativadores da proteína quinase ativada por amp (ampk), seu processo de preparação, e medicamentos
De la Ossa et al. Waste autochthonous tuscan olive leaves (Olea europaea var. olivastra seggianese) as antioxidant source for biomedicine
CN104286842A (zh) 一种解酒护肝的复方组合片
Ali et al. In vitro and in vivo antibiofilm activity of red onion scales: An agro-food waste
Mattioli et al. Tannins-based extracts: effects on gut chicken spontaneous contractility
BR112014014907A2 (pt) composições e métodos para diagnóstico e tratamento de hipertireoidismo em animais de companhia
Jablonský et al. Phytomass valorization by deep eutectic solvents—Achievements, perspectives, and limitations
FI20095606A7 (fi) Järjestelmä ja menetelmä alhaisen suspendoituneen kiintoainepitoisuuden omaavan liuoksen tuottamiseksi ja sellaisen liuoksen käyttö
Cásedas et al. Black mulberries (Morus nigra L.) modulate oxidative stress and beta-amyloid-induced toxicity, becoming a potential neuroprotective functional food
BRPI0508177A (pt) composto, processo para a produção do composto, composição farmacêutica, uso do composto método para o tratamento de uma doença e produto de combinação
BR112012026714A2 (pt) pastilhas de eritritol e isomalte
Sillanpää et al. Tannins can have direct interactions with anthelmintics: Investigations by isothermal titration calorimetry
Calvo et al. Identification of polyphenols in sea fennel (Crithmum maritimum) and Seaside Arrowgrass (Triglochin maritima) extracts with antioxidant, ACE-I, DPP-IV and PEP-inhibitory capacity
Trzaskowska et al. In vitro screening studies on eight commercial essential oils-derived compounds to identify promising natural agents for the prevention of osteoporosis
Osman et al. Effect of technological factors on the extraction of polymeric condensed tannins from acacia species
BR112012011218A2 (pt) uso de um ingrediente ativo polimérico ou oligomérico possuindo um efeito biocida, processo para preparar um artigo médico e artigo médico
Andze et al. Chemically pretreated densification of juniper wood for potential use in osteosynthesis bone implants
Lopes et al. Camel Grass Phenolic Compounds: Targeting Inflammation and Neurologically Related Conditions
Lee et al. Effects of Rosemary extract on C2C12 myoblast differentiation and 5-Aminoimidazole-4-carboxamide ribonucleoside (AICAR)-induced muscle cell atrophy
BRPI0520394A2 (pt) fração ativa de um extrato de látex de euphorbia tirucalli l. com um solvente polar, uso de um ativo de um extrato de euphorbia tirucalli l. com solvente polar, uso de um ou mais compostos de 3-(2,4,6-dodecatrienoil)-ingenol e 3-(2,4,6,8-tetradecatetranoil)-ingenol, composição , uso da composição e processo para obtenção de uma fração ativa de um extrato de euphorbia tirucalli l. com solvente polar
Grzywnowicz et al. Diosmin administration slightly counteracted the changes in bone mechanical properties induced by experimental type 1 diabetes in rats

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06I Publication of requirement cancelled [chapter 6.9 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B25D Requested change of name of applicant approved

Owner name: NAGASAKI UNIVERSITY (JP) ; USAIEN PHARMACEUTICAL C

B25G Requested change of headquarter approved

Owner name: NAGASAKI UNIVERSITY (JP) ; USAIEN PHARMACEUTICAL C

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 23/07/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2822 DE 04-02-2025 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.